Answers are grounded in this paper and cite their sources.
Rationale: Secondary spontaneous pneumothorax (SSP) has recurrence rates as high as 50%, but pleurodesis during index hospitalization can decrease this risk to as low as 5%. Consequently, guidelines recommend offering pleurodesis after the first episode of SSP. Yet, most patients do not receive pleurodesis. It is unclear, however, if pleurodesis use is changing over time or how pleurodesis varies across hospitals. We sought to measure the use of pleurodesis for SSP in the United States, assess for change over time, and quantify variation between hospitals. Methods: We performed a retrospective cohort study of all hospitalizations for SSP in the United States from 2016-2021 using the National Inpatient Sample. The primary exposure of interest was SSP as identified using specific ICD code or with an ICD code for pneumothorax and an associated underlying lung condition. Hospitalizations for patients <18 years of age, or with chronic, traumatic, or iatrogenic pneumothorax were excluded. The primary measure of interest was the annual proportion of SSP hospitalizations undergoing pleurodesis during index hospitalization as identified by ICD procedure codes for surgical or medical pleurodesis. To evaluate variation between hospitals, we fit multi-level mixed effect logistic regression models with hospitalizations nested within hospitals and adjusted for patient and hospital characteristics. We excluded hospitals with fewer than 10 hospitalizations for SSP annually. We measured the intra-class correlation (ICC) and median odds ratio (MOR) to quantify variation across hospitals. Results: Hospitalizations for SSP increased from 61,745 in 2016 to 123,850 in 2021. The use of definitive intervention for hospitalizations with SSP decreased from 25.7% (95% CI:24.8, 26.6) in 2016 to 13.9% (95% CI: 13.3, 14.6) in 2021. In multi-level models adjusted for patient and hospital characteristics, there was large variation in pleurodesis between hospitals (n=911) in 2021 (range 2% to 50%); 6.1% of the variation in the use of definitive interventions was explained at the hospital level. The MOR was 1.56 (95%CI: 1.45-1.70), indicating 56% increased odds of receiving definitive intervention if moving from a hospital with lower use to a hospital with higher usage of pleurodesis (Figure 1). Conclusions: Most patients with SSP do not receive pleurodesis on initial occurrence, and although incidence of SSP has increased, rates of pleurodesis have decreased over time. The use of pleurodesis varies markedly across hospitals, suggesting a lack of standardization in management of this high-risk condition. Future work is needed to identify the barriers to more consistent care in SSP.
No takes yet. Share an insight, caveat, or question.
Keil et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: